Benzinga | Mar 15, 2021 07:10AM EDT

Corbus Pharmaceuticals Q4 EPS $(0.10) Beats $(0.25) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.25) by 60 percent. This is a 75.61 percent increase over losses of $(0.41) per share from the same period last year.